PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 16 analysts with an average price target of $63.65. This is a potential upside of $14.76 (30.19%) from yesterday's end of day stock price of $48.89.

PTC Therapeutics's activity chart (see below) currently has 168 price targets and 219 ratings on display. The stock rating distribution of PTCT is 28.72% HOLD, 53.19% BUY and 18.09% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.69% with an average time for these price targets to be met of 241.46 days.

Highest price target for PTCT is $112, Lowest price target is $33, average price target is $56.43.

Most recent stock forecast was given by TAZEEN AHMAD from BAML on 09-May-2025. First documented stock forecast 14-Feb-2014.

Currently out of the existing stock ratings of PTCT, 27 are a HOLD (28.72%), 50 are a BUY (53.19%), 17 are a SELL (18.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$68

$22.07 (48.05%)

$55

20 days ago
(09-May-2025)

9/11 (81.82%)

$23.77 (53.74%)

23

Hold

$42

$-3.93 (-8.56%)

$56

21 days ago
(08-May-2025)

12/15 (80%)

$-0.51 (-1.20%)

280

Buy

$58

$12.07 (26.28%)

$65

22 days ago
(07-May-2025)

20/27 (74.07%)

$17.24 (42.30%)

157

Buy

$112

$66.07 (143.85%)

$113

22 days ago
(07-May-2025)

5/17 (29.41%)

$71.24 (174.78%)

307

Buy

$67

$21.07 (45.87%)

$75

22 days ago
(07-May-2025)

5/13 (38.46%)

$26.24 (64.38%)

351

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 241.46 days on average for the stock forecasts to be realized with a an average price target met ratio 58.69

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Eric Joseph works at JPMORGAN and has 4 price targets and 3 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with highest potential upside - $66.07

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Heather Behanna with lowest potential downside - -$33.93

PTC Therapeutics in the News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether PTC and certain of its officers and/or directors have engaged in...

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J., May 1, 2025 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that on April 25, 2025, the company approved non-statutory stock options to purchase an aggregate of 7,000 shares of its common stock and 10,780 restricted stock units (“RSUs”), each representing the right to receive one share of its common stock upon vesting,...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?